These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 7482436

  • 1. Fibrinogen Guarenas I: partial characterization of a new dysfibrinogenemia with an altered rate of fibrinopeptide release and an impaired polymerization.
    Lundberg UG, Rodriguez S, Marchi R, Ruiz-Saez A, Arocha-Piñango CL.
    Thromb Res; 1995 Apr 15; 78(2):95-106. PubMed ID: 7482436
    [Abstract] [Full Text] [Related]

  • 2. Fibrinogen Oviedo I. A new Spanish dysfibrinogenaemia.
    Fernández FJ, Rodríguez Pinto C, Páramo J, Cuesta B, Collado M, Rocha E.
    Blood Coagul Fibrinolysis; 1990 Oct 15; 1(4-5):571-5. PubMed ID: 2133236
    [Abstract] [Full Text] [Related]

  • 3. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide.
    Lane DA, Southan C, Ireland H, Thompson E, Kehl M, Henschen A.
    Br J Haematol; 1983 Apr 15; 53(4):587-97. PubMed ID: 6830702
    [Abstract] [Full Text] [Related]

  • 4. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
    Soya K, Terasawa F, Okumura N.
    Thromb Haemost; 2013 Feb 15; 109(2):221-8. PubMed ID: 23238100
    [Abstract] [Full Text] [Related]

  • 5. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His).
    Bögli C, Hofer A, Baudo F, Redaelli R, Furlan M.
    Haemostasis; 1992 Feb 15; 22(1):7-11. PubMed ID: 1521828
    [Abstract] [Full Text] [Related]

  • 6. Fibrinogen Milano. VI: A heterozygous dysfibrinogenemia (A alpha 16 Arg----His) with bleeding tendency.
    Bögli C, Cofrancesco E, Cortellaro M, Della Volpe A, Hofer A, Furlan M, Zanussi C.
    Eur J Haematol; 1990 Jul 15; 45(1):26-30. PubMed ID: 2379562
    [Abstract] [Full Text] [Related]

  • 7. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
    Yan J, Luo M, Cheng P, Liao L, Deng X, Deng D, Lin F.
    Int J Hematol; 2017 Apr 15; 105(4):506-514. PubMed ID: 27933517
    [Abstract] [Full Text] [Related]

  • 8. Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site "a".
    Lounes KC, Soria C, Mirshahi SS, Desvignes P, Mirshahi M, Bertrand O, Bonnet P, Koopman J, Soria J.
    Blood; 2000 Nov 15; 96(10):3473-9. PubMed ID: 11071644
    [Abstract] [Full Text] [Related]

  • 9. Fibrinogen Ledyard (A alpha Arg16----Cys): biochemical and physiologic characterization.
    Lee MH, Kaczmarek E, Chin DT, Oda A, McIntosh S, Bauer KA, Clyne LP, McDonagh J.
    Blood; 1991 Oct 01; 78(7):1744-52. PubMed ID: 1912564
    [Abstract] [Full Text] [Related]

  • 10. Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization.
    Ruf W, Bender A, Lane DA, Preissner KT, Selmayr E, Müller-Berghaus G.
    Biochim Biophys Acta; 1988 May 12; 965(2-3):169-75. PubMed ID: 3365451
    [Abstract] [Full Text] [Related]

  • 11. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations.
    Kotlín R, Suttnar J, Cápová I, Hrachovinová I, Urbánková M, Dyr JE.
    Am J Hematol; 2012 May 12; 87(5):555-7. PubMed ID: 22407772
    [Abstract] [Full Text] [Related]

  • 12. Fibrinogen Birmingham: a heterozygous dysfibrinogenemia (A alpha 16 Arg----His) containing heterodimeric molecules.
    Siebenlist KR, Prchal JT, Mosesson MW.
    Blood; 1988 Mar 12; 71(3):613-8. PubMed ID: 3345340
    [Abstract] [Full Text] [Related]

  • 13. Fibrinogen Seattle II: congenital dysfibrinogenemia with an Arg (A alpha 16)----his substitution.
    Ebert RF, Schreiler WE, Bell WR.
    Thromb Res; 1986 Jul 01; 43(1):7-13. PubMed ID: 3726812
    [Abstract] [Full Text] [Related]

  • 14. Fibrinogen Magdeburg I: a novel variant of human fibrinogen with an amino acid exchange in the fibrinopeptide A (Aalpha 9, Leu-->Pro).
    Meyer M, Kutscher G, Stürzebecher J, Riesener G, Lutze G.
    Thromb Res; 2003 Jan 25; 109(2-3):145-51. PubMed ID: 12706644
    [Abstract] [Full Text] [Related]

  • 15. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
    Tanaka H, Terasawa F, Ito T, Tokunaga S, Ishida F, Kitano K, Kiyosawa K, Okumura N.
    Thromb Haemost; 2001 Jan 25; 85(1):108-13. PubMed ID: 11204560
    [Abstract] [Full Text] [Related]

  • 16. Two cases of dysfibrinogenemia characterized by abnormal FPB release: fibrinogen Madrid I & II.
    Borrell M, Vila L, Solá J, Coll I, Gómez N, González N, Rutllant ML.
    Thromb Res; 1987 Mar 01; 45(5):591-9. PubMed ID: 3109061
    [Abstract] [Full Text] [Related]

  • 17. A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine.
    Yoshida N, Wada H, Morita K, Hirata H, Matsuda M, Yamazumi K, Asakura S, Shirakawa S.
    Blood; 1991 May 01; 77(9):1958-63. PubMed ID: 2018836
    [Abstract] [Full Text] [Related]

  • 18. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia.
    Kotlín R, Chytilová M, Suttnar J, Riedel T, Salaj P, Blatný J, Santrůcek J, Klener P, Dyr JE.
    Thromb Res; 2007 May 01; 121(1):75-84. PubMed ID: 17408725
    [Abstract] [Full Text] [Related]

  • 19. [Functional analysis for dysfibrinogenemias, Toyama and Adachi, which have a mutation of Aalpha16Arg-->His (CGT-->CAT) with aberrant fibrinopeptide A release].
    Soya K, Takezawa Y, Terasawa F, Okumura N.
    Rinsho Byori; 2012 Jun 01; 60(6):499-505. PubMed ID: 22880226
    [Abstract] [Full Text] [Related]

  • 20. ["Fibrinogen Kawaguchi": a hereditary dysfibrinogenemia characterized by defective release of fibrinopeptide A associated with altered polymerization of fibrin monomers].
    Saeki E, Matsuda M, Ichinose A, Samejima Y, Kasamatsu A, Ara R, Mitsuno K, Kihara T, Hara Y.
    Nihon Ketsueki Gakkai Zasshi; 1985 Aug 01; 48(5):1229-35. PubMed ID: 4072586
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.